# Arazlo

NDC: 0187-2098
Generic name: tazarotene
Labeler / Manufacturer: Bausch Health US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: LOTION
Routes: TOPICAL
Marketing started: 20191219

FDA application: NDA211882

## Active ingredients

- TAZAROTENE: .45 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0187-2098"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0187-2098
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d941ff25-c221-4a55-8012-0dcf3bbcbbd1